Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990964 · ClinicalTrials.gov registry record
Attain Success Clinical Trial
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 2,014
- Enrollment target
NCT00990964: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00990964 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 2,014 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00990964 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 2,014 participants
- Enrollment target
Study Summary
The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.
Primary Outcome
Implant success was defined as final successful placement of the Attain Family left-heart lead in the coronary vein branches utilizing the Attain Family of delivery catheters.
Interventions
- DEVICE Attain Success Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,014 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-11 |
What the finished NCT00990964 record still lists
NCT00990964 is an observational study that tracks outcomes without assigning an intervention. Its 2,014 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Attain Success Lead is the first listed.
NCT00990964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00990964 about?
NCT00990964 is a clinical study titled "Attain Success Clinical Trial". The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.
What is the current status of trial NCT00990964?
This trial is currently completed. The enrollment target is 2,014 participants. The study started on 2009-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00990964?
The interventions under investigation include: Attain Success Lead (DEVICE).
Who is sponsoring clinical trial NCT00990964?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia